Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Public Health Genomics and Precision Health Knowledge Base (v7.4)

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov.

HuGE Navigator|HuGE Literature Finder|PHGKB

HuGE Literature Finder

Records 1-15

Query Trace: Glioblastoma and PTEN[original query]

Granular cell astrocytoma: an aggressive IDH-wildtype diffuse gliomarwith molecular genetic features of primary glioblastoma. Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto Similar articles in PubMed
Human Cytomegalovirus (HCMV) infection was not correlated with overall survival in glioblastomas. Neoplasma 2018 Mar 65 (3): 431-435. Han S, Wang P F, Xing Y X, Song H W, Yao K, Lin Z Similar articles in PubMed
Significant effect of anti-tyrosine kinase inhibitor (Gefitinib) on overall survival of the Glioblastoma (GBM) patients in the backdrop of mutational status of EGFR and PTEN genes. Journal of neurosurgical sciences 2018 Feb . Arif Sajad H, Pandith Arshad A, Tabasum Rehana, Ramzan Altaf U, Singh Sarabjeet, Siddiqi Mushtaq A, Bhat Abdul Similar articles in PubMed
High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients. Experimental & molecular medicine 2017 Apr 49 (4): e317. Cho Sung-Yup, Park Changho, Na Deukchae, Han Jee Yun, Lee Jieun, Park Ok-Kyoung, Zhang Chengsheng, Sung Chang Ohk, Moon Hyo Eun, Kim Yona, Kim Jeong Hoon, Kim Jong Jae, Khang Shin Kwang, Nam Do-Hyun, Choi Jung Won, Suh Yeon-Lim, Kim Dong Gyu, Park Sung Hye, Youn Hyewon, Yun Kyuson, Kim Jong-Il, Lee Charles, Paek Sun Ha, Park Hans Similar articles in PubMed
GBM-associated mutations and altered protein expression are more common in young patients. Oncotarget 2016 Aug . Ferguson Sherise D, Xiu Joanne, Weathers Shiao-Pei, Zhou Shouhao, Kesari Santosh, Weiss Stephanie E, Verhaak Roeland G, Hohl Raymond J, Barger Geoffrey R, Reddy Sandeep K, Heimberger Amy Similar articles in PubMed
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin Similar articles in PubMed
Alteration of major vault protein in human glioblastoma and its relation with EGFR and PTEN status. Neuroscience 2015 Jun 297 243-51. Navarro L, Gil-Benso R, Megías J, Muñoz-Hidalgo L, San-Miguel T, Callaghan R C, González-Darder J M, López-Ginés C, Cerdá-Nicolás M Similar articles in PubMed
Somatic mutations in glioblastoma are associated with methylguanine-DNA methyltransferase methylation. Oncology letters 2015 May 9 (5): 2063-2067. McDonald Kerrie L, Tabone Tania, Nowak Anna K, Erber Wendy Similar articles in PubMed
Gene mutation profiling of primary glioblastoma through multiple tumor biopsy guided by 1H-magnetic resonance spectroscopy. International journal of clinical and experimental pathology 2015 8 (5): 5327-35. Tang Chao, Guo Jun, Chen Hong, Yao Cheng-Jun, Zhuang Dong-Xiao, Wang Yin, Tang Wei-Jun, Ren Guang, Yao Yu, Wu Jin-Song, Mao Ying, Zhou Liang- Similar articles in PubMed
Correlation of EGFR, IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab. International journal of oncology 2012 Sep 41 (3): 1029-35. Lv Shasha, Teugels Erik, Sadones Jan, De Brakeleer Sylvia, Duerinck Johnny, Du Four Stephanie, Michotte Alex, De Grève Jacques, Neyns Ba Similar articles in PubMed
Long-term survivors of glioblastoma: clinical features and molecular analysis. Acta neurochirurgica 2009 Nov 151 (11): 1349-58. Sonoda Yukihiko, Kumabe Toshihiro, Watanabe Mika, Nakazato Yoichi, Inoue Tomoo, Kanamori Masayuki, Tominaga Tei Similar articles in PubMed
Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration. American journal of clinical pathology 2009 Feb 131 (2): 257-63. Ruano Yolanda, Ribalta Teresa, de Lope Angel Rodríguez, Campos-Martín Yolanda, Fiaño Concepción, Pérez-Magán Elisa, Hernández-Moneo José-Luis, Mollejo Manuela, Meléndez Bárba Similar articles in PubMed
PTEN gene mutation and high MIB-1 labeling index may contribute to dissemination in patients with glioblastoma. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2004 Jan 11 (1): 37-41. Kato Hideaki, Fujimura Miki, Kumabe Toshihiro, Ishioka Chikashi, Kanamaru Ryunosuke, Yoshimoto Takas Similar articles in PubMed
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. Journal of the National Cancer Institute 2001 Aug 93 (16): 1246-56. Smith J S, Tachibana I, Passe S M, Huntley B K, Borell T J, Iturria N, O'Fallon J R, Schaefer P L, Scheithauer B W, James C D, Buckner J C, Jenkins R Similar articles in PubMed
Significant Effect of Anti-tyrosine Kinase Inhibitor (Gefitinib) on Overall Survival of the Glioblastoma Multiforme Patients in the Backdrop of Mutational Status of Epidermal Growth Factor Receptor and PTEN Genes. Asian journal of neurosurgery 0 13 (1): 46-52. Arif Sajad Hussain, Pandith Arshad Ahmad, Tabasum Rehana, Ramzan Altaf Umar, Singh Sarabjeet, Siddiqi Mushtaq Ahmad, Bhat Abdul Rash Similar articles in PubMed

File Formats Help:

How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?

Page last reviewed:Oct 1, 2020
Page last updated:Jun 09, 2021
Content source:

TOP